Related references
Note: Only part of the references are listed.Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
Joseph J. Lee et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study
Wenjie Ma et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study
Simone Jacobs et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Development, External Validation, and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis
Peter J. Meffert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study
Nita G. Forouhi et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese
Geng Zong et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
The association of pattern of lifetime alcohol use and cause of death in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Manuela M. Bergmann et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers
Sabine Siegert et al.
PLOS ONE (2013)
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
Shira Zelber-Sagi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Plasma Phospholipid Concentration of Cis-Palmitoleic Acid and Risk of Heart Failure
Luc Djousse et al.
CIRCULATION-HEART FAILURE (2012)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
John Willy Haukeland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
High Hepatic SCD1 Activity Is Associated with Low Liver Fat Content in Healthy Subjects under a Lipogenic Diet
Guenther Silbernagel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
Victor de Ledinghen et al.
LIVER INTERNATIONAL (2012)
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
Robert P. Myers et al.
LIVER INTERNATIONAL (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) Gene and Metabolic Risk Factors in the EPIC-Potsdam Study
Maria Arregui et al.
PLOS ONE (2012)
Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study
Janine Kroeger et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study
Jason H. Y. Wu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis
Jose A. M. Carvalho et al.
ANNALS OF MEDICINE (2011)
The Metabolically Benign and Malignant Fatty Liver
Norbert Stefan et al.
DIABETES (2011)
Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population
Jeong H. Kim et al.
LIVER INTERNATIONAL (2011)
Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort
Pinal S. Patel et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men
Helena Petersson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Endogenous red blood cell membrane fatty acids and sudden cardiac arrest
Rozenn N. Lemaitre et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Hepatic Lipid Composition and Stearoyl-Coenzyme A Desaturase 1 mRNA Expression Can Be Estimated from Plasma VLDL Fatty Acid Ratios
Andreas Peter et al.
CLINICAL CHEMISTRY (2009)
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
Anna Kotronen et al.
DIABETES (2009)
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2009)
Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Anne Langsted et al.
CIRCULATION (2008)
Plasma fetuin-A levels and the risk of type 2 diabetes
Norbert Stefan et al.
DIABETES (2008)
Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus
Benno Krachler et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
Leanne Hodson et al.
PROGRESS IN LIPID RESEARCH (2008)
Liver fat in the metabolic syndrome
Anna Kotronen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha
Myeong Jin Yoon et al.
DIABETES (2006)
Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids
C Thamer et al.
HORMONE AND METABOLIC RESEARCH (2005)
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease
F Diraison et al.
DIABETES & METABOLISM (2003)
Share Paper
